Olema Oncology, Inc. (OLMA) bonds
OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$7.22−0.14 (-1.90%)
Close on Nov 17, 2026Market cap $631.73MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Olema Oncology reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Olema Oncology's 10-Q for the period ended Jan 11, 2026
Olema Oncology's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Expires |
|---|---|---|
| Senior Secured Loan Facility | $50.00M | Aug 1, 2027 |
| Amendment of Original Loan Agreement | $100.00M | Jan 1, 2029 |
See a number that looks wrong?